Skip to main content
Sanofi logo

Sanofi — Investor Relations & Filings

Ticker · SAN ISIN · FR0000120578 LEI · 549300E9PC51EN656011 PA Manufacturing
Open in API
Filings indexed 4,405 across all filing types
Latest filing 2026-04-15 Foreign Filer Report
Country FR France
Listing PA SAN

About Sanofi

https://www.sanofi.com/en/directory/

Sanofi is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and marketing of therapeutic solutions. The company's portfolio includes a wide range of medicines and vaccines designed to improve human health. Sanofi focuses on several key therapeutic areas, including immunology, oncology, rare diseases, neurology, and vaccines. Emphasizing a research-driven approach, the company increasingly utilizes artificial intelligence to innovate and accelerate the delivery of new treatments for patients worldwide. Sanofi is also a producer of active pharmaceutical ingredients.

Recent filings

Filing Released Lang Actions
6-K - Sanofi (0001121404) (Filer)
Foreign Filer Report
2026-04-15 English
Sanofi: Informations relatives au nombre de droits de vote et d'actions - MARS 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 75% confidence The document is a regulatory disclosure by sanofi of its total number of shares and voting rights as required by French Commercial Code Article L.233-8 II and AMF Regulation Article 223-16. It is not an operational earnings release or management discussion, nor a full annual or interim report, but a statutory announcement of voting rights. Among the defined categories, "Declaration of Voting Results & Voting Rights Announcements (DVA)" covers such announcements of voting rights structures. Therefore, the correct filing type is DVA.
2026-04-14 French
Sanofi: Information concerning the total number of voting rights and shares - March 2026
Regulatory Filings Classification · 89% confidence The document is a statutory disclosure of total shares and voting rights pursuant to French Commercial Code and AMF regulations. It provides periodic regulatory information rather than announcing a vote result, dividend, or a full report. It does not signal a change in major shareholding thresholds (MRQ) nor issue new capital (SHA). It is a standalone compliance announcement, fitting the fallback category for general regulatory filings (RNS).
2026-04-14 English
Sanofi: Disclosure of trading in own shares
Transaction in Own Shares Classification · 95% confidence The document is a direct disclosure by Sanofi of its purchases of its own shares over a specified period, including aggregated presentation by day and market. This matches the definition of a Transaction in Own Shares (share repurchase/issuance) rather than an announcement of a report, insider dealing by directors, or any other category.
2026-04-13 English
Sanofi : Déclaration des transactions sur actions propres
Transaction in Own Shares Classification · 95% confidence The document is titled ‘Déclaration des transactions sur options propres’ for Sanofi, detailing tables of transactions in its own share options. This is not an insider director dealing disclosure (DIRS), but a listing of the company’s own share/option purchases or issuances. Under our taxonomy, it fits ‘Transaction in Own Shares’ (POS).
2026-04-13 English
Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants
Regulatory Filings Classification · 30% confidence The document is a corporate press release (communiqué de presse) announcing EU regulatory approval of a Sanofi/Regeneron drug. It contains no financial results, shareholder votes, management changes, or structured periodic report data. It is neither an earnings release nor an annual/interim report, nor any other defined category. As a miscellaneous regulatory announcement not fitting specific labels, it falls under the fallback category: Regulatory Filings (RNS).
2026-04-13 French

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.